Physician profile
Eva J Salamon
NPI 1124026570
$817.64
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $127 · 2021: $181 · 2022: $196.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $318.34 | 2019-2022 | |
| Astellas Pharma US INC | $86.57 | 2019-2021 | |
| Therapeuticsmd, INC. | $64.57 | 2019-2021 | |
| Organon LLC | $40.68 | 2021-2022 | |
| Millicent US INC | $37.71 | 2020 | |
| Mylan Pharmaceuticals INC. | $33.90 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $33.03 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $32.33 | 2021 | |
| Amag Pharmaceuticals, INC. | $32.06 | 2019 | |
| Hologic Sales and Service, LLC | $28.75 | 2019-2022 | |
| Amgen INC. | $26.40 | 2019-2022 | |
| Myovant Sciences INC. | $22.58 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.56 | 2022 | |
| Evofem Biosciences, INC. | $14.20 | 2022 | |
| Avion Pharmaceuticals | $13.91 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.05 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Salamon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.